This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Martel Alain: Innovator in Antibiotic Development
Introduction
Martel Alain is a notable inventor based in Delson, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. His innovative work has led to the creation of a unique patent that addresses critical health challenges.
Latest Patents
Martel Alain holds a patent for "Antibiotic C-3 dithioacetal-substituted carbapenem compounds." This patent describes a dithioacetal carbapenem of the formula ##STR1##, where R.sup.1 can be hydrogen or a C.sub.1-6 alkyl group. This invention represents a promising advancement in antibiotic therapy.
Career Highlights
Martel Alain is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development, focusing on innovative solutions to combat bacterial infections. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Martel has collaborated with esteemed colleagues, including Carol Bachand and Jean-Paul Daris. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Martel Alain's contributions to antibiotic development exemplify the impact of innovation in healthcare. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile